Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Shaman Pharmaceuticals has been moving on big, relative, -- Ignore unavailable to you. Want to Upgrade?

To: bargainman who wrote (343)	1/27/1999 11:07:00 PM
From: Daniel Shaffer	Read Replies (1) \| Respond to of 838

Shame on Shaman There is something really amateurish and inept about how Shaman has been running its business. That press release about being "surprised" at some FDA concerns was completely inept, as if Shaman wanted to shout from the rooftops, "Oh my goodness! We weren't prepared for the FDA's concerns, and now we are a day late and a dollar short!" The rest of the release was just as bad, e.g.: "We are also reviewing our corporate partnering strategy and our expenses. All of these issues must be examined against the backdrop of the continued funding required for other research and commercial opportunities at Shaman, and its subsidiary, Shaman Botanicals." It makes it sound like they are in a state of panic. Not very good PR unless that is what they wanted to accomplish. PR is supposed to be self-serving, not self-defeating. I believe that with enough time and money, Shaman Botanicals could generate profits. I just hope they get the chance. Good luck, all you fellow SHMN stockholders. This is truly a problem child we have on our hands: brilliant but not very vigilant or practical.